Association between the cellular p53 and the adenovirus 5 E1B‐55kd proteins reduces the oncogenicity of Ad‐transformed cells.
S J van den Heuvel, A.J. van der Eb, Theo van Laar(The Netherlands Cancer Institute), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), W. Martin Kast(University of Southern California), A. Zantema(Leiden University Medical Center)
Cited by 68
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549